Compare Marsh & McLennan Companies, Inc. (MRSH) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Zoetis Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 2.7× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| MRSH | ZTS | |
|---|---|---|
Market Cap | $87.77B | $31.95B |
Sector | Financials | Health |
52-Week High | $211.21 | $156.76 |
52-Week Low | $157.32 | $71.91 |
Enterprise Value | $108.61B | $39.24B |
Dividend Yield | 2.17% | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
